S-EPMC11833670 - Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers. - OmicsDI

Unknown

Dataset Information

Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.

ABSTRACT:

SUBMITTER: Dowling GP

PROVIDER: S-EPMC11833670 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature